Oncologists have discovered that lung cancer cells can change their identity to resist treatment. Research published in ...

A SIMPLE urine test for lung cancer could be available for NHS use in as little as five years, scientists say. Spotting ...

For years, the relationship between cannabis smoking and lung cancer has been described as unclear or conflicting. Now, a ...

The targeted therapy sunvozertinib was more effective than standard platinum-based chemotherapy as a first-line treatment for patients with advanced non-small cell lung cancer (NSCLC) driven by EGFR ...

Cancer scientists have discovered that lung cancer cells can change their identity to resist treatment. Research published today [27 May] in Molecular Oncology reveals how lung cancer cells can become ...

Scientists, funded by Cancer Research UK, have now passed another hurdle, bringing the test closer to patient use ...

ZEGFROVY ® demonstrated superior anti-tumor efficacy compared to platinum-doublet chemotherapy as a first-line treatment for advanced NSCLC with EGFR exon20ins WU-KONG28 is the first global randomized ...

CHICAGO -- An oral targeted drug reduced the risk of disease progression or death by 35% compared with chemotherapy when given as first-line treatment for non-small cell lung cancer (NSCLC) patients ...

Scientists at University of Cambridge say the NHS could roll out the urine test within five years to detect lung cancers a ...

KRAS is one of the oncogenes most frequently altered in cancer, mutated in approximately one-third of lung adenocarcinomas.

SAN ANTONIO, May 27, 2026--bioAffinity Technologies receives notice of allowance for Mexican patent on methods of predicting the likelihood of lung cancer using flow cytometry.

While more research is still needed in the field, the test could one day be used in GP surgeries and hospitals to catch lung ...